SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Amane Ike, Kazuyuki Shirai, Hiroaki Nishikawa, Atushi Iwata, Eiji Yahiro, Makoto Sugihara, Akira Kawamura, Yoshinari Uehara, Bo Zhang, Masahiro Ogawa, Ken Mori, Shin-ichiro Miura, Keijiro Saku, Associations between different types of hypoglycemic agents and the clinical outcome of percutaneous coronary intervention in diabetic patients—From the FU-Registry, Journal of Cardiology, 2015, 65, 5, 390

    CrossRef

  2. 2
    Philip D. Home, Marie-Paule Dain, Nick Freemantle, Ryuzo Kawamori, Martin Pfohl, Sandrine Brette, Valérie Pilorget, Werner A. Scherbaum, Giacomo Vespasiani, Maya Vincent, Beverley Balkau, Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents, Diabetes Research and Clinical Practice, 2015, 108, 2, 350

    CrossRef

  3. 3
    George Dailey, Edward Wang, A Review of Cardiovascular Outcomes in the Treatment of People with Type 2 Diabetes, Diabetes Therapy, 2014, 5, 2, 385

    CrossRef

  4. 4
    Jonathan Golledge, Frank Quigley, Ramesh Velu, Phillip J Walker, Joseph V Moxon, Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study, Cardiovascular Diabetology, 2014, 13, 1

    CrossRef

  5. 5
    Ronac Mamtani, Kevin Haynes, Brian S. Finkelman, Frank I. Scott, James D. Lewis, Distinguishing incident and prevalent diabetes in an electronic medical records database, Pharmacoepidemiology and Drug Safety, 2014, 23, 2
  6. 6
    C. J. Currie, S. E. Holden, Optimizing clinical outcomes resulting from glucose-lowering therapies in type 2 diabetes: increased confidence about the DPP-4 inhibitors and continued concerns regarding sulphonylureas and exogenous insulin, Diabetes, Obesity and Metabolism, 2014, 16, 10
  7. 7
    Andrea V. Margulis, Elizabeth M. Kang, Tarek A. Hammad, Patterns of Prescription of Antidepressants and Antipsychotics Across and Within Pregnancies in a Population-Based UK Cohort, Maternal and Child Health Journal, 2014, 18, 7, 1742

    CrossRef

  8. 8
    Alan Garber, Martin Abrahamson, Joshua Barzilay, Lawrence Blonde, Zachary Bloomgarden, Michael Bush, Samuel Dagogo-Jack, Michael Davidson, Daniel Einhorn, W. Garvey, George Grunberger, Yehuda Handelsman, Irl Hirsch, Paul Jellinger, Janet McGill, Jeffrey Mechanick, Paul Rosenblit, Guillermo Umpierrez, Michael Davidson, American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement, Endocrine Practice, 2013, 19, Supplement 2, 1

    CrossRef

  9. 9
    Alfonso Soto-González, Diego Bellido-Guerrero, Effectiveness of therapy with basal insulin analogs to improve glycemic control in type 2 diabetes mellitus patients poorly controlled with oral antidiabetic drugs in combination or not with NPH insulin, Journal of Diabetes Research and Clinical Metabolism, 2013, 2, 1, 20

    CrossRef

  10. 10
    G. C. Hall, A. D. McMahon, M.-P. Dain, E. Wang, P. D. Home, Primary-care observational database study of the efficacy of GLP-1 receptor agonists and insulin in the UK, Diabetic Medicine, 2013, 30, 6